President Joe Biden reportedly will take executive action to reopen federal marketplaces selling Affordable Care Act (ACA) health plans; Moderna investigating booster shot designed to be more effective against emerging variants of coronavirus disease 2019 (COVID-19); Brazil coronavirus variant is found in Minnesota.
This week, President Joe Biden plans to take executive action on health insurance as he moves to reopen federal marketplaces selling Affordable Care Act (ACA) health plans and lower barriers to joining Medicaid, according to a report Tuesday in The Washington Post. Citing individuals inside and outside the administration, the effort is aimed at assisting Americans who lost their health insurance as a result of job losses or other factors stemming from the coronavirus disease 2019 (COVID-19) pandemic. Typically, open enrollment would not occur until a restricted 6-week period at the end of the year.
Moderna said it plans to manufacture a COVID-19 booster shot designed to be more effective against emerging variants of the coronavirus amid reports that their approved vaccine is less potent against the variant identified in South Africa. Moderna will test 2 booster-shot options, with 1 targeting the South African variant and the other to fight new mutations. Notably, the company’s approved vaccine showed no reduction in producing neutralizing antibodies against the more contagious, and potentially more lethal, variant discovered in the United Kingdom.
Reported by The Associated Press, the first US-reported case of the novel coronavirus variant identified in Brazil was found in an individual who recently returned from the country to Minnesota. The variant, known as P.1, has raised concern among researchers who say that people who have already been infected with COVID-19 may be at risk of being reinfected with the Brazilian variant. Although reinfection is reportedly rare, there is a confirmed case in Brazil of someone with the new variant who had been infected with a different virus strain several months earlier.
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More